Health Canada authorizes use of the Moderna Spikevax (50 mcg) COVID-19 vaccine in children 6 to 11 years of age
Statement Health Canada has authorized the use of the Moderna Spikevax (50 mcg) COVID-19 vaccine in children 6 to 11 years of age to help protect this younger age group from COVID-19. March 17, 2022 | Ottawa, ON | Health Canada Today, Health Canada authorized the use of the Moderna Spikevax (50 mcg) COVID-19 vaccine…
Read more